Related Experiment Video
Updated: Sep 7, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Monocyte anisocytosis increases during multisystem inflammatory syndrome in children with cardiovascular
Lael M Yonker1,2,3, Oluwakemi Badaki-Makun4,5, Puneeta Arya6,7
1Department of Pediatrics, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. lyonker@mgh.harvard.edu.
Insights
A novel monocyte anisocytosis index (MDW) effectively identifies children with multisystem inflammatory syndrome (MIS-C) and cardiac risks. This rapid test aids early diagnosis and treatment initiation for MIS-C, improving patient outcomes.
Area of Science:
- Pediatric critical care medicine
- Hematology
- Infectious diseases
Background:
- Multisystem inflammatory syndrome in children (MIS-C) is a severe post-SARS-CoV-2 complication requiring prompt diagnosis.
- Current diagnostic methods for MIS-C are complex and time-consuming.
- There is an urgent need for rapid diagnostic assays to expedite MIS-C evaluation and treatment.
Purpose of the Study:
- To evaluate the efficacy of monocyte anisocytosis, measured by monocyte distribution width (MDW), as a rapid screening tool for MIS-C.
- To assess the performance of MDW in identifying children with MIS-C, particularly those at risk for cardiac complications.
- To compare the diagnostic accuracy of MDW with existing tier 1 laboratory tests for MIS-C.
Main Methods:
- Monocyte distribution width (MDW) was measured in blood samples from children diagnosed with MIS-C and control groups.
- A discovery cohort (April 2020-October 2020) established an MDW threshold for MIS-C identification.
- A validation cohort (October 2020-October 2021) tested the MDW threshold's utility across multiple institutions.
Main Results:
- In the discovery cohort, an MDW threshold of 24.0 showed 100% sensitivity and 80% specificity for MIS-C.
- The validation cohort confirmed 100% sensitivity for MDW > 24.0 in identifying MIS-C.
- MDW demonstrated superior diagnostic accuracy compared to other routine hematologic parameters and decreased with disease resolution.
Conclusions:
- Monocyte anisocytosis, detected by MDW on routine CBC, significantly improves early identification of children with MIS-C.
- This rapid assay facilitates timely intervention for MIS-C, especially in cases with cardiac involvement.
- The findings suggest MDW can enhance current clinical practice guidelines for MIS-C evaluation.
Background:
Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening complication that can develop weeks to months after an initial SARS-CoV-2 infection. A complex, time-consuming laboratory evaluation is currently required to distinguish MIS-C from other illnesses. New assays are urgently needed early in the evaluation process to expedite MIS-C workup and initiate treatment when appropriate. This study aimed to measure the performance of a monocyte anisocytosis index, obtained on routine complete blood count (CBC), to rapidly identify subjects with MIS-C at risk for cardiac complications.
Methods:
We measured monocyte anisocytosis, quantified by monocyte distribution width (MDW), in blood samples collected from children who sought medical care in a single medical center from April 2020 to October 2020 (discovery cohort). After identifying an effective MDW threshold associated with MIS-C, we tested the utility of MDW as a tier 1 assay for MIS-C at multiple institutions from October 2020 to October 2021 (validation cohort). The main outcome was the early screening of MIS-C, with a focus on children with MIS-C who displayed cardiac complications. The screening accuracy of MDW was compared to tier 1 routine laboratory tests recommended for evaluating a child for MIS-C.
Results:
We enrolled 765 children and collected 846 blood samples for analysis. In the discovery cohort, monocyte anisocytosis, quantified as an MDW threshold of 24.0, had 100% sensitivity (95% CI 78-100%) and 80% specificity (95% CI 69-88%) for identifying MIS-C. In the validation cohort, an initial MDW greater than 24.0 maintained a 100% sensitivity (95% CI 80-100%) and monocyte anisocytosis displayed a diagnostic accuracy greater that other clinically available hematologic parameters. Monocyte anisocytosis decreased with disease resolution to values equivalent to those of healthy controls.
Conclusions:
Monocyte anisocytosis detected by CBC early in the clinical workup improves the identification of children with MIS-C with cardiac complications, thereby creating opportunities for improving current practice guidelines.
More Related Videos
09:41Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction
Myocarditis III: Medical Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies